Showing results (11-20 of 55) with videos related to

Sort By:
Pageof 6
Seminars in Arthritis and Rheumatism|January 9, 2016
Direct and indirect costs for systemic lupus erythematosus in Sweden. A nationwide health economic study based on five defined cohortsAndreas Jönsen, Frida Hjalte, Minna Willim, et al.
Rheumatology (Oxford, England)|January 19, 2010
The BILAG multi-centre open randomized controlled trial comparing ciclosporin vs azathioprine in patients with severe SLEBridget Griffiths, Paul Emery, Vicky Ryan, et al.
The Journal of Rheumatology|November 3, 2012
Development and assessment of users' satisfaction with the systemic lupus erythematosus disease activity index 2000 responder index-50 websiteZahi Touma, Dafna D Gladman, Anne MacKinnon, et al.
The Journal of Rheumatology|January 17, 2018
Smoking Is the Most Significant Modifiable Lung Cancer Risk Factor in Systemic Lupus ErythematosusSasha Bernatsky, Rosalind Ramsey-Goldman, Michelle Petri, et al.
Oncology|October 11, 2013
Non-lymphoma hematological malignancies in systemic lupus erythematosusMary Lu, Sasha Bernatsky, Rosalind Ramsey-Goldman, et al.
Arthritis Care & Research|January 29, 2014
25-hydroxyvitamin D and cardiovascular disease in patients with systemic lupus erythematosus: data from a large international inception cohortApinya Lertratanakul, Peggy Wu, Alan Dyer, et al.
Arthritis Care & Research|May 20, 2014
Electrocardiographic findings in systemic lupus erythematosus: data from an international inception cohortJosiane Bourré-Tessier, Murray B Urowitz, Ann E Clarke, et al.
The Journal of Rheumatology|April 3, 2014
American College of Rheumatology criteria at inception, and accrual over 5 years in the SLICC inception cohortMurray B Urowitz, Dafna D Gladman, Dominique Ibañez, et al.
Lupus Science & Medicine|September 22, 2016
Off-label use of rituximab for systemic lupus erythematosus in EuropeMonica Rydén-Aulin, Dimitrios Boumpas, Irene Bultink, et al.
Annals of the Rheumatic Diseases|January 11, 2013
Lymphoma risk in systemic lupus: effects of disease activity versus treatmentSasha Bernatsky, Rosalind Ramsey-Goldman, Lawrence Joseph, et al.
Pageof 6